We welcome you to our official website of 20th Euro Congress on Psychiatrists & Psychologists, during August 07-08, 2017 at Rome, Italy. The theme is based on “Achieving mental wellness by understanding human mind through Psychiatric approaches”.
Psychiatrists and Neurologists have been increased in recent years. 895 psychiatrists were certified and registered by the end of the 2009. One psychiatrist per 9.000 inhabitants was roughly noted. People are suffering from reduced unemployment, family breakdown, suicide, and homelessness due to untreated mental illness. The second causes of disabilities are Neuropsychiatric disorders. In Europe about 29% of adult population had at least one mental disorder arising from substance use, Psychosis, eating disorders, Anxiety, and Depression. Mental illness affects all age groups. It shows more impact on Young people
Importance and Scope:
Mental illness in Italy is increasing rapidly. The rates of mental illness from 1990-2005 are as follows: substance use 1.0% (0.4–2.4), mood 6.6% (5.5–8.1), anxiety 9.7% (7.6–12.2), and impulse 0.3% (0.1–1.2) disorders. Life time Prevalence: substance use 8.3% (6.2–11.0), anxiety 15.0% (12.3–18.1), and mood 15.6% (13.5–18.1) disorders. Women are 3.7 time more likely to get mental illness than in men from Anxiety and mood disorders. Substance abuse is commonly seen in men. Economic crisis such as Unemployment, Poverty are main stressors leads to mental health difficulties such as anxiety and depression.
Aim of this conference is stimulate new ideas for treatment that will be beneficial across the spectrum of various psychiatric disorders.
Psychiatry Conferences, Psychiatry Meetings National symposiums and Workshops provide a dedicated forum for the advancement, execution and exchange of information about brain disorders and its allied areas.
Why to attend???
Euro Psychiatrists 2017 will provide an opportunity for all stakeholders working on mental health issues to talk about their work. Euro Psychiatrists 2017 will congregate renowned speakers, principal investigators, experts, psychiatrist and researchers from both academia and health care industry will join together to discuss their views and research. The Psychiatrists Meeting will be comprised of sessions by world class experts in the field of psychiatry. In Euro Psychiatrists 2017, international symposiums, B2B meetings, international workshops will also be organized to discuss the specific topics in the field of Psychiatry.
Euro Psychiatrists 2017 Highlights includes:
Earn up to 21 CME Credits
CPD Credits by CPD Standards Office, UK
IOCM Certification
One on One Meeting with Eminent Speakers from 40 Countries
Live Streaming of the conference
Keynote sessions by world’s most eminent researchers at Psychological Disorder research
Top Industries Representation
Thought provoking Symposia’s and Workshops
Preconference workshops in all major countries
Nominations for Best Poster Award
Outstanding Young Researcher Award
Group Registration benefits
Track 1:Psychiatry
Track 1-1Neurodevelopmental disorder
Track 1-2Liaision Psychiatry
Track 1-3Cognition diseases as in various forms of dementia
Track 1-4Clinical psychiatry
Track 1-5Molecular psychiatry
Track 1-6Community psychiatry
Track 1-7Biological psychiatry
Track 1-8Learning disability
Track 1-9Cross-cultural psychiatry
Track 1-10Social psychiatry
Track 2:Psychology
Track 2-1Clinical Psychology
Track 2-2Health Psychology
Track 2-3Counseling Psychology
Track 2-4Positive Psychology
Track 2-5Applied Psychology
Track 2-6Rehabilitation Psychology
Track 2-7Sports Psychology
Track 2-8Educational Psychology
Track 2-9Industrial Psychology
Track 3:Child and Adolescent Psychology
Track 3-1Neonatal and Pediatric health
Track 3-2Sex and drugs
Track 3-3Bullying and Aggression
Track 3-4Anxiety
Track 3-5Dyslexia
Track 3-6Phobia
Track 3-7Mood dysregulation disorder
Track 3-8Attachment disorder
Track 3-9Autism
Track 3-10ADHD
Track 3-11Self-esteem
Track 4:Psychosis And Adverse Behavior
Track 4-1Stress and psychosis
Track 4-2Auditory hallucinations
Track 4-3Recovery and psychosis
Track 4-4Relationships between trauma and psychosis
Track 5:Schizophrenia and Bipolar Disorder
Track 5-1Onset of schizophrenia
Track 5-2Visual and auditory hallucinations
Track 5-3Schizophrenia and brain systems
Track 5-4Genetics of schizophrenia
Track 5-5Advanced treatment in bipolar disorders
Track 5-6Imaging of bipolar disorder
Track 5-7Genetics of bipolar disorder
Track 5-8Manic and depressive episodes
Track 6:Dissociative and Addictive Disorders
Track 6-1Anxiety disorder
Track 6-2Obsessive compulsive disorder
Track 6-3Panic disorder
Track 6-4Behavioral and cyber addiction
Track 6-5Drug addiction
Track 6-6Alcoholism and substance abuse
Track 6-7Addiction treatment and rehabilitation
Track 7:Personality Disorders
Track 7-1Paranoid personality disorder
Track 7-2Borderline personality disorder
Track 7-3Multiple personality disorder
Track 7-4Antisocial personality disorder
Track 8:Psychooncology
Track 8-1Paediatrics psychooncology
Track 8-2Psychooncology Model of Care
Track 8-3Palliative Care Psychiatry
Track 9:Neuropsychology and brain/behavioral disorders
Track 9-1Emotional Disorder
Track 9-2Amnesia
Track 9-3Dementia
Track 9-4Alzheimer
Track 10:Recovery and Psychotherapy
Track 10-1psychotherapy
Track 10-2Psychosurgery and brain pacemaker
Track 10-3Deep brain stimulation and its side effects
Track 10-4Neurofeedback mechanism
Track 10-5Antipsychotic drugs
Track 11:Mental health and Psychiatric Complications
Track 11-1Eating Disorder
Track 11-2Mental health care
Track 11-3Mental illness
Track 11-4Psychosexual disorder
Track 11-5Somatoform Disorder
Track 11-6Sleep Disorder
Track 11-7Depressive Disorder
Track 11-8Psychosomatic disorder
Track 11-9Neurocognitive Disorder
Track 11-10Mental retardation
Track 12:Post-Traumatic Stress Disorder
Track 12-1Family violence and domestic harassment
Track 12-2Psychological abuse and trauma
Track 12-3Depression and chronic pain
Track 12-4Symptoms and risk factors of PTSD
Track 13:Psychoactive Medication
Track 13-1Psychoactive medication
Track 13-2Psychopharmacology
Track 13-3Psychopathology
Track 13-4Dopamine in antidepressant drugs
Track 13-5Addiction of psychoactive drugs
Track 13-6Akt/GSK3 signaling in the action of psychotropic drugs
Track 14:Geriatric Psychiatry
Track 14-1Psychogeriatrics
Track 14-2Old age mental disorders
Track 14-3Geriatric depression and treatment
Track 14-4Clinical geriatrics
Track 15:Forensic and Emergency Psychiatry
Track 15-1Recent developments in forensic psychiatry
Track 15-2Risk assessment and case studies
Track 15-3Ethical issues in forensic psychiatry
Track 15-4Criminal Psychology
Track 15-5Computational forensics
Track 15-6Prevention of psychiatric disorders
Track 15-7Psychiatric care
Track 15-8Psychiatric rehabilitation
Track 16:Psychiatric Nursing
Track 16-1Mental health nursing
Track 16-2Adult nursing
Track 16-3Pediatric Nursing
Track 16-4Learning disability nursing
Track 16-5Occupational therapist
Track 16-6Paramedical nursing
Track 16-7Social worker
Track 17:Advanced Therapeutics For Psychiatric Disorders
Track 17-1Botulinum toxin: An emerging therapeutic towards treatment of depression
Track 17-2Dialectical behavior therapy
Track 17-3Transcranial magnetic stimulation therapy
Track 17-4Identification of biomarkers for early diagnosis
Track 17-5Implementation of mindfulness-based therapies
Track 17-6Telepsychiatry
Track 17-7Alternative/Herbal medicine in psychiatry
Track 18:Entrepreneurs Investment Meet
08月07日
2017
08月08日
2017
注册截止日期
留言